Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Millet

Psychiatry Raleigh, NC Medical Doctor

NPI 1134168347 CMS profile 96473

7850 Brier Creek Pkwy, Raleigh, NC 27617

Open in the dashboard

General payments

$476,248

1,171 records reported · program years 2019–2025

Research payments

$1,336

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$41,215 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Robert Millet of Raleigh, NC is reported in the CMS Open Payments database as having received $476,248 across 1,171 general payments and $1,336 in research payments paid to them. Separately, studies naming them as principal investigator received $41,215 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,746 229
2024 General $78,602 156
2023 General $106,794 321
2022 General $66,996 173
2021 General $27,942 43
2020 General $26,726 58
2019 General $84,442 191
2019 Research $1,336 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Millet
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Robert Millet were reported at $84,746. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Robert Millet Psychiatry median Middle half National median
2019 $84,442 $184 $59–$605 $163
2020 $26,726 $119 $36–$372 $114
2021 $27,942 $143 $43–$576 $132
2022 $66,996 $153 $50–$590 $149
2023 $106,794 $170 $56–$651 $160
2024 $78,602 $179 $57–$673 $164
2025 $84,746 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $447,933 507 payments
  2. Janssen Scientific Affairs, LLC $5,754 3 payments
  3. Supernus Pharmaceuticals, Inc. $4,566 8 payments
  4. ITI, Inc. $4,457 91 payments
  5. Teva Pharmaceuticals USA, Inc. $4,044 79 payments
  6. AbbVie, Inc. $1,571 104 payments
  7. Otsuka America Pharmaceutical, Inc. $1,064 54 payments
  8. Neurocrine Biosciences, Inc. $967 41 payments
  9. Lundbeck LLC $757 37 payments
  10. Alkermes, Inc. $672 26 payments
  11. Other $4,464 221 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $303,048 131 payments
  2. Consulting Fee $96,310 20 payments
  3. Travel and Lodging $53,051 128 payments
  4. Food and Beverage $23,605 887 payments
  5. Education $235 5 payments
Products named General payments · program years 2019–2025
  1. SPRAVATO $423,537 461 payments
  2. INVEGA SUSTENNA $35,961 60 payments
  3. INVEGA TRINZA $28,562 49 payments
  4. CAPLYTA $4,082 70 payments
  5. REXULTI $813 38 payments
  6. VRAYLAR $785 49 payments
  7. INGREZZA $693 32 payments
  8. ARISTADA Cns $672 26 payments
  9. ARISTADA Cns $672 26 payments
  10. ARISTADA Cns $596 22 payments
  11. Other $10,102 542 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Otsuka Pharmaceutical Development & Commercialization, Inc. $1,336 7 payments

Records

1,178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record